Non-transplantable Recurrence After Resection for Transplantable Hepatocellular Carcinoma: Implication for Upfront Treatment Choice

2021 ◽  
Author(s):  
Xu-Feng Zhang ◽  
Feng Xue ◽  
Fabio Bagante ◽  
Francesca Ratti ◽  
Hugo P. Marques ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Treatment Choice

Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome

2015 ◽  
Vol 19 (8) ◽  
pp. 1466-1475 ◽  
Author(s):  
Xiaoyan Xie ◽  
Chunlin Jiang ◽  
Zhengwei Peng ◽  
Baoxian Liu ◽  
Wenjie Hu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Local Recurrence ◽  
Treatment Choice

scholarly journals Systemic therapy of advanced hepatocellular carcinoma

2020 ◽  
Author(s):  
Peter R Galle ◽  
Jean-François Dufour ◽  
Markus Peck-Radosavljevic ◽  
Jörg Trojan ◽  
Arndt Vogel
Keyword(s):  
Hepatocellular Carcinoma ◽  
Standard Of Care ◽  
Treatment Choice ◽  
Current Evidence ◽  
Advanced Hepatocellular Carcinoma ◽  
Second Line ◽  
Systemic Treatments ◽  
First Time ◽  
Systemic Therapies

For a decade, sorafenib remained the only approved first-line treatment and standard of care for advanced hepatocellular carcinoma. The treatment landscape has been evolving rapidly over the past 2 years with the approval of additional first-and second-line systemic treatments, most of which are targeted therapies. The expected approval of immunotherapies constitutes a paradigm shift: for the first time in years, a checkpoint inhibitor in combination with a VEGF antibody recently outperformed sorafenib with regards to efficacy. The wider availability of systemic therapies increases the chance for longer overall survival but raises new questions concerning the role of local options, treatment choice and sequential treatment. Following an expert discussion at the German Cancer Congress 2020 in Berlin, this article aims to summarize the current evidence on and experience of treatment choice and sequence in first- and second-line therapy.

Multimodality treatment of hepatocellular carcinoma

1998 ◽  
Vol 13 (11-s4) ◽  
pp. S315-S319 ◽  
Author(s):  
ZHAO-YOU TANG ◽  
XIN-DA ZHOU ◽  
ZENG-CHEN MA ◽  
ZHI-QUAN WU ◽  
JIA FAN ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multimodality Treatment

Hepatocellular carcinoma

1982 ◽  
Vol 118 (1) ◽  
pp. 69-70 ◽  
Author(s):  
A. J. Bennett
Keyword(s):  
Hepatocellular Carcinoma

Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplanation

2001 ◽  
Vol 120 (5) ◽  
pp. A90-A90
Author(s):  
N ESNAOLA ◽  
G LAUWERS ◽  
N MIRZA ◽  
D NAGORNEY ◽  
D DOHERTY ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Microvascular Invasion
Sign in / Sign up

Export Citation Format

Share Document